Literature DB >> 1972179

Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium.

A Slungaard1, G M Vercellotti, G Walker, R D Nelson, H S Jacob.   

Abstract

Eosinophils (EOs) participate in a variety of inflammatory states characterized by endothelial cell damage, such as vasculitis, pneumonitis, and endocarditis. We find that 100 U/ml TNF-alpha/cachectin (TNF), a concentration attainable in the blood of humans with parasitic infestations, stimulates highly purified populations of EOs to damage human umbilical vein endothelial cells (HUVEC), a model of human endothelium. This TNF-dependent EO cytotoxicity is strongly inhibited by heparin and methyprednisolone but unaffected by the platelet-activating factor antagonist BN52012 or scavengers of superoxide anion and H2O2, superoxide dismutase and catalase. However, addition of a physiologically relevant concentration of Br- (100 microM) enhances EO/TNF damage to HUVEC, implicating the possible participation of EO peroxidase (EPO) in the killing mechanism. EOs adherent to FCS-coated plastic wells more than double their production of superoxide anion and the cytotoxic EPO-derived oxidant HOBr when exposed to TNF, showing that TNF activates the respiratory burst of EOs attached to a "physiologic" surface. Unlike PMNs, EOs were not irreversibly activated to kill unopsonized endothelium by previous exposure to TNF, and did not degranulate or upregulate CR3 expression as detected by Mo1 in the presence of 100 U/ml TNF. HUVEC exposed 18 h to TNF were considerably more susceptible to lysis by PMA-activated EOs and reagent H2O2, demonstrating a direct effect of TNF upon endothelium, perhaps through inhibition of antioxidant defenses. These findings suggest that abnormally elevated serum levels of TNF may provoke EOs to damage endothelial cells and thereby play a role in the pathogenesis of tissue damage in hypereosinophilic states.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972179      PMCID: PMC2187940          DOI: 10.1084/jem.171.6.2025

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

Review 1.  Eosinophilia and heart disease.

Authors:  C M Oakley; G J Olsen
Journal:  Br Heart J       Date:  1977-03

2.  Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism.

Authors:  S H Pincus; A E Butterworth; J R David; M Robbins; M A Vadas
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

3.  The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature.

Authors:  J E Parrillo; J S Borer; W L Henry; S M Wolff; A S Fauci
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

4.  In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.

Authors:  H E Heslop; D J Gottlieb; A C Bianchi; A Meager; H G Prentice; A B Mehta; A V Hoffbrand; M K Brenner
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

5.  Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro.

Authors:  J W Kazura; M M Fanning; J L Blumer; A A Mahmoud
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

6.  Effects of corticosteroids on eosinophil chemotaxis and adherence.

Authors:  L C Altman; J S Hill; W M Hairfield; M F Mullarkey
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

7.  Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.

Authors:  D L Wassom; D A Loegering; G O Solley; S B Moore; R T Schooley; A S Fauci; G J Gleich
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein.

Authors:  F Kierszenbaum; S J Ackerman; G J Gleich
Journal:  Am J Trop Med Hyg       Date:  1981-07       Impact factor: 2.345

9.  Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.

Authors:  S J Weiss; J Young; A F LoBuglio; A Slivka; N F Nimeh
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

10.  Studies of endotoxin-induced decrease in lipoprotein lipase activity.

Authors:  M Kawakami; A Cerami
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Oxidant stress in asthma.

Authors:  R Dworski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

3.  Transcriptional control of viral gene therapy by cisplatin.

Authors:  James O Park; Carlos A Lopez; Vinay K Gupta; Charles K Brown; Helena J Mauceri; Thomas E Darga; Abdullah Manan; Samuel Hellman; Mitchell C Posner; Donald W Kufe; Ralph R Weichselbaum
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

4.  Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2.

Authors:  Y Ishii; C A Partridge; P J Del Vecchio; A B Malik
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

5.  Increased tumour necrosis factor alpha production by neutrophils in patients with hepatitis B.

Authors:  X Fan; Z Zhang
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

6.  No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Authors:  Carole Eboumbou Moukoko; Nasureldin El Wali; O K Saeed; Qurashi Mohamed-Ali; Jean Gaudart; Alain J Dessein; Christophe Chevillard
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 7.  Targeting TNF-alpha: a novel therapeutic approach for asthma.

Authors:  Christopher Brightling; Mike Berry; Yassine Amrani
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

8.  The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma.

Authors:  Hae-Seong Nam; Sook Young Lee; Seung Jun Kim; Ju Sang Kim; Soon Seog Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Jeong Sup Song; Sung Hak Park; Seok Chan Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

9.  Hypereosinophilia with multiple thromboembolic cerebral infarcts and focal intracerebral hemorrhage.

Authors:  Eun Ju Lee; Young-Jun Lee; Seung Ro Lee; Dong Woo Park; Hyun Young Kim
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

10.  Expired breath condensate hydrogen peroxide concentration and pH for screening cough variant asthma among chronic cough.

Authors:  Amina Hamed Ahmad Al Obaidi
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.